OakChart

WW International Inc

WWHealthcare·Medical Care Facilities·USA·Micro·NASD·Nov 11 • 3:14 PM ET

13.21+1.19 (9.91%)
2026-11-11 21:15 CET
Market cap
120.19 USD m
Revenue, TTM
646.30 USD m
Net income, TTM
-28.65 USD m
Free cash flow, TTM
20.15 USD m
EPS diluted, TTM
-2.87
P/E
-
Compare

Price

WW against its 20, 50 and 200-day averages
2050200beat
10.0015.0020.0025.00639K1.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26WWclose 13.2120-day 13.3050-day 14.62200-day 15.6813.2152w low

62.5% under the 52-week high of 35.25 on 9 Jan 2026. 52-week low 8.37 on 8 May 2026. Last 15 sessions, 52.3% high to low

Volume 1.62× normal · the line is the 50-bar volume average

Profile

WW
52-week range, 18% of the way up
8.3635.25

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: United States, Germany, and Other. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

Employees3500
IPOJun 30, 2025
Beta4.36
ATR, 14d1.40
Rel volume1.62
Short float23.39%
Insider own12.44%
Inst own75.17%

Snapshot

6 groups

Valuation

Index-
Market Cap132.10M
Enterprise Value425.91M
Income-28.65M
Sales646.30M
Book/sh29.33
Cash/sh13.23
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3500
IPOJun 30, 2025

Ratios

P/E-
Forward P/E-
PEG-
P/S0.20
P/B0.45
P/C1.00
P/FCF6.56
EV/EBITDA6.62
EV/Sales0.66
Quick Ratio1.75
Current Ratio1.75
Debt/Eq1.45
LT Debt/Eq1.45
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.87
EPS next Y-1.01
EPS next Q-0.69
EPS this Y-142.64%
EPS next Y68.58%
EPS next 5Y-
EPS past 3/5Y- 150.47%
Sales past 3/5Y-11.92% -12.41%
EPS Y/Y TTM-102.54%
Sales Y/Y TTM-11.74%
EPS Q/Q126.18%
Sales Q/Q-11.15%
EarningsNov 05 BMO
EPS/Sales Surpr.138.74% 0.38%

Ownership

Insider Own12.44%
Insider Trans6.82%
Inst Own75.17%
Inst Trans6.03%
ROA-3.16%
ROE-9.30%
ROIC-3.99%
Gross Margin59.56%
Oper. Margin-4.15%
Profit Margin-4.43%
SMA20-0.63%
SMA50-9.66%
SMA200-15.73%
Trades-

Technical

Shs Outstand10.00M
Shs Float8.75M
Short Float23.39%
Short Ratio8.81
Short Interest2.05M
52W High35.25 -62.52%
52W Low8.36 57.93%
Volatility17.68% 10.17%
ATR (14)1.40
RSI (14)48.30
Beta4.36
Rel Volume1.62
Avg Volume232.16K
Volume334,081

Performance

Perf Week8.91%
Perf Month-12.51%
Perf Quarter-8.57%
Perf Half Y37.05%
Perf YTD-54.78%
Perf Year-53.50%
Perf 3Y-83.01%
Perf 5Y-94.24%
Perf 10Y-90.27%
Recom2.00
Target Price27.50
Prev Close12.02
Price13.21
Change %9.91%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Oct 02, 2026InitiatedNNorthland CapitalOutperform$25+89.2%
Sep 15, 2025InitiatedCCJS SecuritiesMarket Perform

Peers

Mkt cap
TickerCompanyMkt cap
LFMDLifeMD Inc85.36M
MEDMedifast Inc147.16M
HIMSHims & Hers Health Inc4.81B
HLFHerbalife Ltd1.62B
BODIBeachbody Company Inc27.57M
SMPLSimply Good Foods Co1.10B
XPOFXponential Fitness Inc233.80M
PTONPeloton Interactive Inc2.59B
NUSNu Skin Enterprises Inc190.57M
PLNTPlanet Fitness Inc4.66B

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BYE STEPHEN JPresident and CEONov 10 '26Buy11.0112,500137,62512,500Nov 10 05:56 PM
Gavales Lisa ADirectorNov 10 '26Buy11.035,00055,1255,000Nov 10 05:56 PM
Sjoqvist Nikolaj HDirectorAug 18 '26Buy13.847,235100,13219,620Aug 20 04:01 PM
DellaFortuna FeliciaCFO & Member, IOCEMay 22 '26Buy12.681,50019,0121,500May 27 04:56 PM
DAVIS EUGENE IDirectorMay 27 '26Buy14.7310,000147,32921,648May 27 04:55 PM
DAVIS EUGENE IDirectorMay 22 '26Buy12.6310,000126,25110,000May 27 04:55 PM
DAVIS EUGENE IDirectorMay 26 '26Buy13.481,64822,21811,648May 27 04:55 PM
Sjoqvist Nikolaj HDirectorMay 20 '26Buy9.5510,00095,50012,385May 21 04:01 PM
Volkmann JonathanChief Ops Off. & Member, IOCEMay 21 '26Buy10.081,50015,1203,196May 21 04:01 PM
Hawks CarneyDirectorMay 20 '26Buy10.0120,000200,25651,442May 21 04:01 PM
Hawks CarneyDirectorNov 19 '25Buy22.1429,057643,46429,057Nov 20 04:01 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWCiShares Micro-Cap ETFAUM: 1.22B
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B
EESWisdomTree U.S. SmallCap FundAUM: 684.87M
DEEPAcquirers Small and Micro Deep Value ETFAUM: 25.47M
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B

News

latest 14 of 200
  • WW International Crushes EPS Estimates On Cost Discipline, But Shrinking Clinical Base And Flat Revenue Outlook Temper The Beat (Earnings Whispers) +5.85%
  • Weight Watchers Announces Third Quarter 2026 Results (GlobeNewswire)
  • WW's Earnings Test: Can Lower Marketing Spend Keep Profits Rising As Clinical Growth Cools? (Earnings Whispers) +5.04%
  • Weight Watchers Schedules Third Quarter 2026 Earnings Conference Call (GlobeNewswire)
  • Weight Watchers and Google Health Launch Weight Health Collaboration for Employers and Payers (InvestorsHub) +13.77%
  • Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs (GlobeNewswire)
  • WW International appoints Stephen Bye as president and CEO (InvestorsHub) -16.95%
  • Weight Watchers Appoints Stephen Bye as Chief Executive Officer (GlobeNewswire)
  • Weight Watchers to Participate in Morgan Stanley Annual Global Healthcare Conference (GlobeNewswire)
  • WW International shares rise 3.1% in after-hours trading (InvestorsHub)
  • WW International Inc (WW) (Q2 2026) Earnings Call Highlights: Clinical Growth and Debt ... (GuruFocus.com) +9.54%
  • Weight Watchers Announces Second Quarter 2026 Results (GlobeNewswire) -6.72%
  • Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call (GlobeNewswire) -8.14%
  • Sam's Club and Weight Watchers Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-051.5100.6331.510152.9152.324
2026Q22026-08-051.4100.4801.407162.32159.133
2026Q12026-05-07-5.200-2.447-5.202168.26158.533
2025Q42026-03-16-0.580-0.847-0.584162.81149.83
2025Q32025-11-06-5.7600.510-5.759172.09161.383
2025Q22025-08-117.893-0.025119.19189178.052
2025Q12025-05-28-2.040--0.906186.57--
2024Q42025-02-270.320-0.310184.41--
2024Q32024-11-060.240--0.579192.89--
2024Q22024-08-01--0.293202.07--
2024Q12024-05-09---4.392206.55--
2023Q42024-02-28---1.114205.96--
2023Q32023-11-02--0.542214.87--
2023Q12023-05-04---1.681241.9--
2022Q42023-03-06---0.461223.92--
2022Q22022-08-04---0.066269.45--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-1.325-1.5707.550710.64699.71
2026FY--3.215--628.54
2027FY--1.010--629.34
2028FY-0.200--636.2

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-05303143.3142.93143.66
2026Q4S2026-11-04300146.88146.3147.44
2026Q4S2026-10-20300146.87146.26147.44
2026Q4S2026-10-01302146.87146.26147.44
2026Q4S2026-08-06202147.17146.9147.44
2026Q4S2026-07-21200148.93148.4149.47
2026Q4S2026-05-07202148.93148.4149.47
2026Q4S2026-03-16201151.88151.6152.16
2026Q4S2026-01-20100159.05159.05159.05
2026Q4S2025-11-11110159.05159.05159.05
2026Q4S2025-11-10110159.05159.05159.05
2026Q4S2025-11-09110159.05159.05159.05
2026Q4S2025-11-08110159.05159.05159.05
2026Q4S2025-11-07110159.05159.05159.05

Estimate history

EPS, annual2.3963.1911.721.0720.946-3.653-1.464-4.344105.685-2.8712
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.5790.31-0.906119.194-5.759-0.584-5.2021.4071.508
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1306.9111514.1211413.3371378.1241212.4631039.835889.551785.921710.638646.3
Period201720182019202020212022202320242025TTM
Sales, quarterly192.887184.413186.571189.164172.091162.812168.261162.324152.901
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual64.68966.95667.41968.97370.06470.55679.18980.0519.9929.999
Period201720182019202020212022202320242025MRQ
Shares, quarterly79.73480.05180.26109.9879.9929.9969.9999.999
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue646.30710.64785.92889.551,039.841,212.461,378.121,413.341,514.12
Cost of Goods Sold Incl. D&A261.35249.05250.31339.13416.66461.72560.56616.52647.71
Gross Profit384.95461.58535.61550.42623.18750.74817.57796.82866.41
Selling, General and Administrative Excl. Other411.79410.57451.68470.71496.81525.26548.22493.79477.40
Research and Development28.6442.19-------
Other Operating Expense0.000.000.000.000.007.1415.058.400.00
Operating Income-26.8451.0283.9379.71126.36218.34254.29294.62389.01
Interest Expense45.6963.41112.50108.8778.0577.64111.09134.46139.51
Unusual Expense-34.06-1,111.79320.1557.38410.3352.4138.136.642.86
Net Income Before Taxes-37.151,091.45-345.18-73.63-366.8076.6792.50150.96244.06
Income Taxes-8.5035.450.5338.62-109.949.7717.4631.5120.49
Consolidated Net Income-28.651,056.01-345.70-112.25-256.8766.8975.04119.45223.57
Net Income From Continuing Operations-28.651,056.01-345.70-112.25-256.8766.8975.08119.62223.75
Net Income-28.651,056.01-345.70-112.25-256.8766.8975.08119.62223.75
EPS (Recurring)-5.2427.80-1.53-0.940.431.461.451.793.22
EPS (Basic, Before Extraordinaries)-2.87105.69-4.34-1.46-3.650.961.111.783.38
EPS (Diluted)-2.87105.69-4.34-1.46-3.650.951.071.723.19
EBITDA64.37118.70121.72132.18170.16266.89304.97339.64433.07
Non-Operating Income (Expense)1.32-7.943.5512.91-4.78-11.63-12.57-2.56-2.58
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.133.636.5713.3410.3516.1744.1018.3324.20
Price To Earnings Ratio--0.26------
Price To Sales Ratio0.240.41-------
Gross Margin59.5664.9568.1561.8859.9361.9259.3256.3857.22
Operating Margin-4.157.1810.688.9612.1518.0118.4520.8525.69
Net Margin-4.43148.60-43.99-12.62-24.705.525.458.4614.78
Shares Outstanding10.009.9980.0579.1970.5670.0668.9767.4266.96
Market Capitalization120.19120.19291.72------

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue152.90162.32168.26162.81172.09189.16186.57184.41
Cost of Goods Sold Incl. D&A51.9168.7870.4570.2168.3654.2653.9355.84
Gross Profit100.9993.5497.8192.61103.73134.90132.65128.57
Selling, General and Administrative Excl. Other64.4884.24127.38135.6986.4877.77123.83102.04
Research and Development5.246.448.098.877.4514.75--
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income36.519.30-29.57-43.0917.2657.138.8226.53
Interest Expense10.8611.5911.4711.7712.0511.9827.6027.03
Unusual Expense0.00-4.780.87-30.159.22-1,130.7829.02-9.69
Net Income Before Taxes25.802.92-41.18-24.69-4.361,170.51-50.0113.38
Income Taxes10.69-11.1510.82-18.8653.16-21.4322.57-11.74
Consolidated Net Income15.1114.07-52.00-5.83-57.521,191.94-72.5825.12
Net Income From Continuing Operations15.1114.07-52.00-5.83-57.521,191.94-72.5825.12
Net Income15.1114.07-52.00-5.83-57.521,191.94-72.5825.12
EPS (Recurring)1.511.07-5.14-2.70-5.1140.04-0.650.23
EPS (Basic, Before Extraordinaries)1.511.41-5.20-0.58-5.76119.19-0.910.31
EPS (Diluted)1.511.41-5.20-0.58-5.76119.19-0.910.31
EBITDA49.6135.22-3.69-16.7842.7666.1015.7335.21
Non-Operating Income (Expense)0.150.420.740.02-0.34-5.41-2.214.19
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.550.550.550.470.002.530.710.56
Price To Earnings Ratio-0.150.120.260.23---
Price To Sales Ratio0.240.240.200.410.370.40--
Gross Margin66.0557.6358.1356.8860.2871.3171.1069.72
Operating Margin23.885.73-17.57-26.4610.0330.204.7314.39
Net Margin9.888.67-30.90-3.58-33.42630.11-38.9013.62
Shares Outstanding10.0010.0010.009.999.9910.0080.2680.05
Market Capitalization120.19159.78137.35291.77273.242,423.85--

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments166.5856.03109.37178.33153.79165.89182.74236.9783.05
Short Term Receivables16.3814.4314.9424.2729.3234.5530.5227.2523.91
Inventories0.000.000.0720.5330.5739.4627.2025.8531.73
Other Current Assets30.6532.1955.1058.2057.4959.2954.9376.3570.29
Total Current Assets213.60102.65179.47281.33271.17299.19295.39366.42208.99
Net Property, Plant & Equipment11.0557.8472.01103.92127.12171.04206.0552.2047.98
Total Investments and Advances0.000.490.002.450.000.000.40398.000.00
Intangible Assets690.80355.35693.17606.051,003.70981.18970.39960.82956.86
Deferred Tax Assets16.4816.6919.6822.2511.2613.6214.3216.23-
Other Assets14.8217.2617.6812.4315.6916.1411.77-379.1332.18
Total Assets946.76550.28982.031,028.431,428.931,481.171,498.311,414.541,246.00
Short Term Debt Incl. Current Port. of LT Debt1.268.179.6217.9920.37105.64129.6177.0082.75
Accounts Payable9.2117.8018.5118.8922.4423.0529.0627.1024.36
Income Tax Payable6.012.341.611.651.757.813.6422.62-
Other Current Liabilities110.06145.02175.73158.04184.57203.60231.75214.60235.92
Total Current Liabilities126.54173.33205.46196.56229.13340.10394.07341.32343.03
Long Term Debt467.361,474.961,479.921,490.391,496.291,510.451,608.481,669.711,740.61
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities34.0214.7641.9925.08157.72173.71175.24190.26143.59
Other Liabilities0.771.5915.742.182.205.122.3518.2930.29
Total Liabilities628.691,664.651,743.121,714.211,885.342,029.382,180.142,219.572,257.52
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity318.07-1,114.37-761.09-685.78-456.40-548.21-685.54-808.94-1,015.99
Total Shareholders Equity318.07-1,114.37-761.09-685.78-456.40-548.21-685.54-808.94-1,015.99
Accumulated Minority Interest0.000.000.000.000.000.003.723.914.47
Total Equity318.07-1,114.37-761.09-685.78-456.40-548.21-681.82-805.03-1,011.52
Total Liabilities & Stockholders Equity946.76550.28982.031,028.431,428.931,481.171,498.311,414.541,246.00
Book Value Per Share31.83-13.92-9.61-9.72-6.51-7.95-10.17-12.08-15.71
Tangible Book Value Per Share-37.30-18.36-18.36-18.31-20.84-22.17-24.56-26.43-30.50
Full-Time Employees3,5003,7004,8507,1007,70010,00017,00018,00018,000
Price to Book Ratio0.410.90-------
Return on Assets141.08-45.12-11.17-20.914.605.048.2116.8212.99
Return on Invested Capital134.45-95.87-15.62-31.926.437.8012.9625.9922.57
Quick Ratio1.690.590.871.331.050.760.681.000.52
Current Ratio1.690.590.871.431.180.880.751.070.61

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-28.651,056.01-345.70-112.25-256.8766.8975.04119.45223.57
Depreciation91.1667.6837.7852.4743.8048.5550.6845.0244.06
Other Funds (Non Cash)-4.00-1,136.23328.1533.87426.8766.5486.4539.9238.83
Funds from Operations80.864.41-6.34-6.1067.97166.42210.73194.96292.78
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-60.72-33.31-10.5012.788.68-9.14-74.79-12.572.81
Income Taxes Payable-45.40-27.071.02-0.21-0.59-7.013.02-18.1027.32
Cash from Operating Activities20.15-28.90-16.846.6976.65157.28135.94182.38295.59
Capital Expenditures-26.36-17.48-16.41-36.30-38.25-37.65-50.43-47.98-46.81
Net Assets From Acquisitions-1.00-2.020.00-38.36-4.35-12.84-10.04-4.06-7.10
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.00-0.00-0.01-0.03-0.04-2.27-5.12-0.58-10.04
Other Sources0.000.000.000.000.00---0.00
Cash from Investing Activities-27.35-19.50-16.41-74.70-42.64-52.75-65.59-52.62-63.96
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.720.004.478.181.0833.42
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.720.004.478.181.0833.42
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-36.81170.040.000.000.00-101.91-96.25-177.00-82.75
Change in Long Term Debt-36.81170.040.000.000.00-101.91-96.25-177.00-82.75
Issuance of Long Term Debt0.00170.040.000.000.001,462.090.000.000.00
Reduction of Long Term Debt-36.810.000.000.000.00-1,564.00-96.25-177.00-82.75
Net Financing Active Other Cash Flow0.00-16.14-17.34-3.47-4.72-14.10-7.46-7.07-25.02
Other Financing Activities Uses0.00-16.14-17.34-3.47-4.72-14.10-7.46-7.07-25.02
Cash from Financing Activities-36.81153.90-17.34-2.75-4.72-111.54-95.54-182.99-74.35
Exchange Rate Effect-1.314.56-2.251.80-4.75-5.088.34-1.00-3.36
Net Change in Cash-45.33110.06-52.85-68.9624.53-12.09-16.85-54.24153.92
Free Cash Flow20.15-28.98-17.564.2074.58154.84114.45165.22276.54
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow7.69--------
Deferred Taxes & Investment Tax Credit-16.95-26.5819.82-145.83-15.56-1.44-9.42-13.67

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments132.24107.29126.67166.58177.57185.43
Short Term Receivables11.9815.9216.8616.3814.9011.71
Inventories0.000.000.000.000.000.00
Other Current Assets17.2723.6724.8230.6526.8566.08
Total Current Assets161.48146.88168.34213.60219.32263.22
Net Property, Plant & Equipment8.129.0310.0311.0512.1213.20
Total Investments and Advances0.000.000.000.000.000.06
Intangible Assets646.65653.20671.53690.80707.70726.62
Deferred Tax Assets16.2116.0716.2516.4816.3016.73
Other Assets14.8715.2614.9114.8213.3113.30
Total Assets847.33840.44881.07946.76968.751,033.12
Short Term Debt Incl. Current Port. of LT Debt0.920.9927.991.261.269.10
Accounts Payable19.6422.5417.089.2111.3410.20
Income Tax Payable1.642.3310.316.0116.453.04
Other Current Liabilities69.9080.2185.72110.06103.92117.72
Total Current Liabilities92.11106.07141.09126.54132.96140.06
Long Term Debt425.13425.32440.20467.36467.69468.12
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities36.2529.8633.7034.0244.4743.30
Other Liabilities0.580.540.500.770.650.67
Total Liabilities554.07561.79615.50628.69645.76652.15
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity293.27278.65265.57318.07322.99380.97
Total Shareholders Equity293.27278.65265.57318.07322.99380.97
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity293.27278.65265.57318.07322.99380.97
Total Liabilities & Stockholders Equity847.33840.44881.07946.76968.751,033.12
Book Value Per Share29.3327.8726.5731.8332.3438.10
Tangible Book Value Per Share-35.34-37.46-40.61-37.30-38.52-34.56
Full-Time Employees---3,500--
Price to Book Ratio0.410.600.430.900.72-2.05
Return on Assets-3.16-10.81136.46141.08141.98133.34
Return on Equity-9.30-30.71----
Return on Invested Capital2.102.00-7.37-0.74-7.27140.38
Quick Ratio1.751.381.191.691.651.88
Current Ratio1.751.381.191.691.651.88

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income15.1114.07-52.00-5.83-57.521,191.94
Depreciation13.0525.9225.8926.3125.498.97
Other Funds (Non Cash)0.33-4.58-0.270.52-0.18-1,168.64
Funds from Operations34.7231.46-26.7041.38-31.1430.30
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.40-7.19-6.85-44.2728.05-68.21
Income Taxes Payable-0.69-7.984.32-41.0513.44-15.92
Cash from Operating Activities32.3124.27-33.55-2.89-3.09-37.91
Capital Expenditures-6.96-6.14-5.80-7.46-3.50-3.35
Net Assets From Acquisitions0.000.000.00-1.00-1.020.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.00-0.00-0.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-6.96-6.14-5.80-8.45-4.52-3.35
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-36.810.000.000.00-1.30
Change in Long Term Debt0.00-36.810.000.000.00-1.30
Issuance of Long Term Debt0.000.000.000.000.00-1.30
Reduction of Long Term Debt0.00-36.810.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.00-16.05
Other Financing Activities Uses0.000.000.000.000.00-16.05
Cash from Financing Activities0.00-36.810.000.000.00-17.35
Exchange Rate Effect-0.41-0.70-0.570.36-0.312.98
Net Change in Cash24.95-19.37-39.91-10.99-7.92-55.64
Free Cash Flow32.3124.27-33.55-2.89-3.10-37.99
Price to Free Cash Flow7.69-----

Revenue breakdown

Behavioral Subscription Revenues2024: 698.99M
Clinical Subscription Revenues2024: 78.00M
Other Revenues, Net2024: 8.93M
Canada2024: 29.67M
Germany2024: 82.65M
Other countries2024: 131.63M
United States2024: 541.97M
United States2024: 785.92M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3023.39%2.0M8.8M222.10K
2026-10-1521.43%1.9M8.8M227.15K
2026-09-3022.09%1.9M8.8M217.43K
2026-09-1519.51%1.7M8.8M189.37K
2026-08-3120.40%1.8M8.8M191.14K
2026-08-1418.49%1.7M9.0M217.30K
2026-07-3122.56%2.0M8.9M238.97K
2026-07-1520.69%1.8M8.9M286.33K
2026-06-3021.67%1.9M8.9M339.40K
2026-06-1521.14%1.9M8.9M378.81K
2026-05-2920.15%1.8M8.9M371.34K
2026-05-1521.01%1.9M9.0M339.32K
2026-04-3019.02%1.9M9.9M326.72K
2026-04-1518.75%1.8M9.9M302.00K
2026-03-3113.90%1.4M9.9M311.19K
2026-03-1315.07%1.5M9.9M271.99K
2026-02-2715.64%1.5M9.9M273.78K
2026-02-1316.18%1.6M9.9M311.77K
2026-01-3012.43%1.2M10.0M323.56K
2026-01-159.40%0.9M10.0M346.02K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.509.7011.9012.0014.1189.000.000.991-0.0170.001
call5.007.209.3012.307.86037.000.000.983-0.0170.001
call7.504.806.8010.305.30628.000.000.900-0.0730.004
call10.002.903.602.832.0428448.000.839-0.0630.005
call12.501.101.551.101.44620824.000.635-0.0730.008
call15.000.300.450.401.28262629.000.298-0.0520.007
call17.500.100.500.101.9764750.000.222-0.0680.006
call20.000.002.350.582.4895490.000.190-0.0780.006
call22.500.001.550.452.9085330.000.171-0.0860.005
call25.000.002.300.303.2521250.000.158-0.0910.005
call30.000.000.350.253.9032,8560.000.142-0.0980.005
call35.000.000.500.204.1951,5860.000.113-0.0810.004
call40.000.002.200.204.4193050.000.104-0.0930.004
put2.500.002.150.005.5700.000.00-0.010-0.0160.001
put5.000.000.050.102.9491770.00-0.020-0.0140.001
put7.500.000.700.103.5911010.00-0.100-0.0720.004
put10.000.100.450.232.1571380.00-0.163-0.0610.005
put12.500.501.051.981.7346520.00-0.365-0.0720.008
put15.002.052.752.331.97077.003.00-0.702-0.0500.007
put17.503.905.304.312.79425.001.00-0.777-0.0660.006
put20.005.907.805.303.25420.000.00-0.799-0.0810.006
put22.507.8010.609.504.2612.000.00-0.829-0.0830.005
put25.0010.7013.5011.405.0904.000.00-0.831-0.0950.005
put30.0015.4018.400.005.6200.000.00-0.880-0.0790.004
put35.0021.3023.500.006.4250.000.00-0.890-0.0850.004
put40.0025.4028.900.007.3980.000.00-0.896-0.0890.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-10SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-10SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-13SCHEDULE 13G/ASEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-013Initial statement of beneficial ownership of securities2026-10-01SEC
2026-09-218-K/A2026-09-09SEC
2026-09-098-KCurrent report2026-09-09SEC
2026-08-26SCHEDULE 13G/ASEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-17SCHEDULE 13G/ASEC
2026-06-158-KCurrent report2026-06-12SEC
2026-06-04DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11192.75K200
2026-100000
2026-090000
2026-08100.13K100
2026-070000
2026-060000
2026-05625.69K700
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-11643.46K100

Institutional holders

Manager% owned
COOPER CREEK PARTNERS MANAGEMENT LLC9.62%
ARISTEIA CAPITAL, L.L.C.7.06%
MILLENNIUM MANAGEMENT LLC5.62%
UBS Group AG5.40%
CARRONADE CAPITAL MANAGEMENT, LP4.68%
Fund 1 Investments, LLC4.23%
VANGUARD CAPITAL MANAGEMENT LLC4.21%
Cygnus Capital Advisors, LLC3.89%
BlackRock, Inc.3.12%
PRELUDE CAPITAL MANAGEMENT, LLC2.95%

Funds

Fund% owned
Western Asset Diversified Income Fund58.72%
NYLIM MacKay High Yield Corporate Bond Fund56.80%
Invesco Senior Floating Rate Fund56.56%
Transamerica High Yield Bond48.73%
NYLIM MacKay Short Duration High Income Fund22.55%
Guggenheim Macro Opportunities Fund19.15%
Western Asset Management Strategic Bond Opportunities Portfolio19.10%
Western Asset High Income Fund II Inc.13.48%
Western Asset Short Duration High Income Fund12.74%
NYLIM VP MacKay High Yield Corporate Bond Portfolio12.13%

OakChart. WW. Cached 15 minutes.